Bioequivalence Study in Healthy Subjects

NCT00844324 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Candesartan cilexetil
DRUG: Candesartan cilexetil

Sponsor

AstraZeneca